Wolverine Trading
EDIT icon

Wolverine Trading’s Editas Medicine EDIT Stock Holding History

Wolverine Trading’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,600
Closed -$19.5K – 4956
2025
Q1 		$19.5K Sell
15,600
-14,200
-48% -$20.9K ﹤0.01% 4562
2024
Q4 		$35.8K Buy
29,800
+17,500
+142% +$44.6K ﹤0.01% 5043
2024
Q3 		$42.8K Buy
12,300
+1,600
+15% +$6.96K ﹤0.01% 4559
2024
Q2 		$50K Sell
10,700
-800
-7% -$4.51K ﹤0.01% 4218
2024
Q1 		$85.3K Buy
+11,500
New +$95.6K ﹤0.01% 4094
2023
Q3 		– Sell
-11,800
Closed -$96.2K – 4642
2023
Q2 		$96.2K Buy
+11,800
New +$103K ﹤0.01% 3785
2022
Q4 		– Sell
-28,800
Closed -$350K – 4239
2022
Q3 		$350K Buy
28,800
+5,500
+24% +$85.7K ﹤0.01% 2995
2022
Q2 		$285K Sell
23,300
-20,700
-47% -$277K ﹤0.01% 3125
2022
Q1 		$859K Buy
44,000
+600
+1% +$11.2K ﹤0.01% 2607
2021
Q4 		$1.21M Sell
43,400
-26,100
-38% -$898K ﹤0.01% 2409
2021
Q3 		$2.95M Buy
69,500
+12,100
+21% +$663K ﹤0.01% 1744
2021
Q2 		$2.65M Buy
57,400
+6,300
+12% +$233K ﹤0.01% 1703
2021
Q1 		$2.07M Sell
51,100
-4,900
-9% -$279K ﹤0.01% 1899
2020
Q4 		$4.28M Buy
+56,000
New +$2.3M 0.01% 1169
2020
Q3 		– Sell
-19,400
Closed -$569K – 4653
2020
Q2 		$569K Sell
19,400
-10,700
-36% -$280K ﹤0.01% 2596
2020
Q1 		$610K Sell
30,100
-100
-0.3% -$2.52K ﹤0.01% 2446
2019
Q4 		$891K Buy
30,200
+8,400
+39% +$210K ﹤0.01% 2524
2019
Q3 		$490K Buy
21,800
+3,600
+20% +$89.2K ﹤0.01% 2649
2019
Q2 		$450K Sell
18,200
-11,700
-39% -$279K ﹤0.01% 2821
2019
Q1 		$731K Sell
29,900
-31,600
-51% -$715K ﹤0.01% 2370
2018
Q4 		$1.27M Buy
61,500
+50,600
+464% +$1.38M ﹤0.01% 1772
2018
Q3 		$347K Buy
+10,900
New +$352K ﹤0.01% 3560

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wolverine Trading's EDIT Position: Q2 2025 in Review

Wolverine Trading sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 11,527 shares — an estimated $18.9K sold.

Wolverine Trading first reported a position in EDIT in Q2 2019 and held it in 14 quarters. The position peaked at $1.69M in Q1 2021. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

  • Wolverine Trading reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 11,527 Editas Medicine shares in Q2 2025, an estimated $18.9K.
  • Wolverine Trading first reported a position in Editas Medicine in Q2 2019 and held it in 14 quarters.
  • Wolverine Trading's Editas Medicine position peaked at $1.69M in Q1 2021.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.